Category: Biotech

Biotech medicine Research integrity

Indestructible Sumitran-Holgersson: Commit misconduct on patients, get EU funding to continue

Swedish start-up Verigraft received €2.2 Million from European Union, to further develop regenerative medicine technology tainted by research misconduct and patient abuse. The founder of this very company: Suchitra Sumitran-Holgersson. A clinical trial is scheduled based on debunked science of recellurising dead blood vessel grafts.